
Variant Bio
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Seattle, Washington, United States, North America
Region: Washington
Country: US
Continent: North America
About
Variant Bio leverages human genetic diversity to develop life-saving therapies, focusing on understanding how genes influence health traits. The company integrates genetics, drug discovery, molecular biology, anthropology, and ethics to advance genomic drug discovery and partnerships worldwide. Based in Seattle, Variant Bio highlights ethical engagement and benefit-sharing with partner communities as a core principle of its research model. Its work aims to transform drug development by using human genetics to identify molecular targets and improve clinical outcomes.
Variant Bio is a biotechnology company that leverages human genetic diversity to identify therapeutic targets for neurodegenerative, autoimmune, and cardiometabolic diseases. The firm integrates genomic research with ethical community partnerships to develop novel medicines and enhance clinical trial success rates.
Variant Bio, Inc.
2018
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Series B
127700000
1m-10m
private
Investors
Founders
Kaja Wasik
Stephane Castel
Leadership
Technology Stack
Products
Genomic Drug Discovery Platform: A platform that uses human genetic diversity to identify molecular targets for drug development.
Research Partnerships and Collaborations: Collaborative research projects with global populations and institutions to study genetics related to health traits and diseases.
VB-Inference Analysis Platform: An analytical platform used to identify and validate genetic targets for therapeutic development.
Ethically-Guided Genomic Research Services: Services that conduct genomic research with a focus on ethical standards, privacy, and benefit-sharing with partner communities.
Funding rounds
SERIES_B · 105000000 · (2021-11-01T00:00:00) · Lead: General Catalyst
SERIES_A · 24700000 · (2019-10-01T00:00:00)